Copyright
©The Author(s) 2015.
World J Hepatol. May 28, 2015; 7(9): 1238-1243
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1238
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1238
Table 1 Risk factors of hepatic artery thrombosis
| Operative factors | Non operative factors |
| Surgical technique | Donor age of more than 60 yr |
| Number of anastomosis | Long cold ischemia time |
| Use of conduits | Preservation damage |
| Vessels kinking | Lack of blood group compatibility |
| Small vessels size | Cytomegalovirus-positive donor status |
| Hypercoagulable recipient status | |
| Recipient cigarette smoking | |
| Rejection | |
| Primary sclerosing cholangitis |
Table 2 Factors involved in development of hypercoagulability after liver transplantation
| Endogenous | Acquired |
| Substantial surgical damage | Donor with factor V Leiden mutation |
| Stasis as a result of clamping of major vessels | Infections |
| Release of activators from the donor liver | Viral infection like cytomegalovirus |
| Systemic inflammatory responses | Perioperative haemostatic agent |
| The quality of the graft | Fresh frozen plasma |
| The length of surgery | Platelets |
| The technique of graft preservation | Recombinant factor VIIa |
| Cold ischemia/reperfusion effect | Anti-fibrinolytics |
| Aprotinin Aminocaproic acid |
- Citation: Algarni AA, Mourad MM, Bramhall SR. Anticoagulation and antiplatelets as prophylaxis for hepatic artery thrombosis after liver transplantation. World J Hepatol 2015; 7(9): 1238-1243
- URL: https://www.wjgnet.com/1948-5182/full/v7/i9/1238.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i9.1238
